Related Experiment Video
Updated: Aug 16, 2026
Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
Published on: October 12, 2014
Tea catechins attenuate ventricular remodeling and graft arterial diseases in murine cardiac allografts
Jun-ichi Suzuki1, Masahito Ogawa, Yuko M Sagesaka
1Department of Cardiovascular Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. jsuzuki.cvm@tmd.ac.jp
Insights
Tea catechins effectively suppress chronic cardiac allograft rejection by reducing inflammation and ventricular remodeling. This study demonstrates their potential in preventing graft arterial disease through modulation of immune responses.
Area of Science:
- Immunology
- Cardiology
- Pharmacology
Background:
- Tea catechins possess diverse biological functions, primarily through the suppression of inflammatory factors.
- The impact of catechins on cardiac allograft rejection remains largely unexplored.
Purpose of the Study:
- To investigate the potential of catechins in attenuating ventricular remodeling and graft arterial diseases (GAD) in cardiac transplant recipients.
- To elucidate the underlying mechanisms by which catechins influence immune responses in cardiac allografts.
Main Methods:
- Oral administration of catechins to murine cardiac recipients.
- Analysis of inflammatory markers, immune cell infiltration, fibrosis, and graft arterial disease.
- Mechanistic studies included immunohistochemistry, RNase protection assays, gel mobility shift assays, and cell proliferation assays.
Main Results:
- Untreated allografts showed significant myocardial infiltration, fibrosis, and GAD with elevated inflammatory factors.
- Catechin treatment attenuated these rejection markers, indicating a protective effect.
- Catechins modulated the Th1/Th2 cytokine balance, suppressed NF-kappaB activation, and reduced cell proliferation.
Conclusions:
- Catechins demonstrate potent anti-rejection properties in cardiac transplantation.
- They critically suppress proinflammatory signaling pathways, offering a therapeutic strategy against chronic rejection.
- Catechins represent a promising agent for managing cardiac allograft complications.
Objective:
Tea catechins have many biological functions; these effects are induced by the suppression of several inflammatory factors. However, effects of catechins on cardiac allograft rejection have not been well investigated.
Methods And Results:
To test the hypothesis that catechins can attenuate ventricular remodeling and graft arterial diseases (GAD) in cardiac rejection, we orally administered catechins to murine cardiac recipients. We analyzed the mechanisms using immunohistochemistry, RNase protection, gel mobility shift, and cell proliferation assays. Although severe myocardial cell infiltration, fibrosis, and GAD with enhancement of inflammatory factors were observed in untreated class II mismatch allografts at day 60, catechins attenuated these changes with altered Th1/Th2 cytokine balance and suppressed NF-kappaB activation and cell proliferation.
Conclusion:
Catechins are potent agents for the suppression of chronic rejection because they are critically involved in the suppression of proinflammatory signaling pathways.
